Matthew Sloan

Matthew Sloan MD, MSc, FRCPC
Assistant Professor
Brain and Therapeutics, Addictions Program
Contact Info
Location
Centre for Addiction & Mental Health
33 Russell Street
7th Floor, Rm. T709
Toronto, ON, M5S 2S1
Appointment Status Primary
Degree/Qualification
MD
MSc
FRCPC
Appointments
Assistant Professor, Division of Brain and Therapeutics, Department of Psychiatry, University of Toronto Clinician Scientist, Addiction Division, Centre for Addiction and Mental Health

Dr. Sloan is an early-career clinician scientist specializing in Addiction Psychiatry. He completed medical school and psychiatry residency at McGill University. Afterwards, he trained as a Visiting Fellow in the Section on Human Pharmacology at the National Institute on Alcohol Abuse and Alcoholism in Bethesda, Maryland, where he gained expertise in using human laboratory paradigms to study alcohol use disorder. Following this, he completed clinical subspecialty training in Addiction Psychiatry at Yale University in New Haven, Connecticut. He has published 15 peer-reviewed manuscripts and 4 book chapters, including peer-reviewed articles in high-impact journals such as The American Journal of Psychiatry and Neuropsychopharmacology. The two main foci of his recent research are the clinical and genetic determinants of alcohol self-administration and the relationship between the endocannabinoid system and alcohol consumption in humans. He is also interested in better understanding the determinants of treatment response in addiction and investigating novel medications for the treatment of alcoholism and other substance use disorders.

Publications and Awards

Recent Publications

Selected Publications

Sloan M.E., Klepp T.D., Gowin J.L., Swan J.E., Sun H., Stangl B.L., Ramchandani V.A. (2018). The OPRM1 A118G Polymorphism: Converging Evidence Against Associations with Alcohol Sensitivity and Consumption. Neuropsychopharmacology. 43(7), 1530-1538.

Gowin J.L.*, Sloan M.E.*, Stangl B.L., Vatsalya V., Ramchandani V.A. (2017). Vulnerability for Alcohol Use Disorder and Rate of Alcohol Consumption. American Journal of Psychiatry. 174(11), 1094-1101. B.

Sloan M.E.*, Gowin J.L.*, Janakiraman R., Ester C.D., Stoddard J., Stangl B.L., Ramchandani V.A (2020). High-Risk Social Drinkers and Heavy Drinkers Display Similar Rates of Alcohol Consumption. Addiction Biology. 25(2), e12734.

Honours and Awards

Selected Honours and Awards

Sloan M.E., Klepp T.D., Gowin J.L., Swan J.E., Sun H., Stangl B.L., Ramchandani V.A. (2018). The OPRM1 A118G Polymorphism: Converging Evidence Against Associations with Alcohol Sensitivity and Consumption. Neuropsychopharmacology. 43(7), 1530-1538.

Gowin J.L.*, Sloan M.E.*, Stangl B.L., Vatsalya V., Ramchandani V.A. (2017). Vulnerability for Alcohol Use Disorder and Rate of Alcohol Consumption. American Journal of Psychiatry. 174(11), 1094-1101. B.

Sloan M.E.*, Gowin J.L.*, Janakiraman R., Ester C.D., Stoddard J., Stangl B.L., Ramchandani V.A (2020). High-Risk Social Drinkers and Heavy Drinkers Display Similar Rates of Alcohol Consumption. Addiction Biology. 25(2), e12734.